Skip to main content
Premium Trial:

Request an Annual Quote

Integrated DNA Technologies, Clear Labs Ink Supply Agreement for Food Safety Testing

NEW YORK – Integrated DNA Technologies of Coralville, Iowa,said today that it has signed a multi-year agreement with Menlo Park, California-based Clear Labs to act as the primary supplier of next-generation sequencing oligo products for Clear Lab's NGS-based food safety platform

The firms believe the collaboration will help provide food producers with fast and high-quality food safety testing using IDT's oligo products.

According to Clear Labs, its Clear Safety platform allows users to detect food-based pathogens, including several strains of Listeria, as well as visualize contamination incidents on maps of food plants. 

"Our NGS products are often used to help research into complex diseases, such as cancer," Roman Terrill, senior VP at IDT, said in a statement. "Our oligos met all the requirements set out by Clear Labs for their innovative approach to NGS-based food safety." 

Financial details of the agreement were not disclosed. 

"Maintaining the accuracy of our testing platform is paramount, and so we have strict requirements for quality, quantity, speed, and performance from our supplier partners," Ramin Khaksar, senior VP of research and development at Clear Labs, said in a statement. "IDT meets all of our exacting needs and is able to fill our quantity requirements while delivering the necessary oligo-specific QC capabilities, [which] a something that array-based providers could not offer."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.